Charlie Gard Case: American Doctor Arrives Examine Terminally Ill Baby

Toni Houston
July 18, 2017

Michio Hirano, M.D. of the Department of Neurology at Columbia University is now in London England to spend 2 days examining Charlie Gard with doctors at Great Ormond Street Hospital.

Charlie will be examined early this week, in London, by Dr. Michio Hirano, a neurologist at New York's Columbia University Medical Center. For the past several months, Gard's parents and the Great Ormond Street Hospital have been in a legal battle over what is in the child's best interest.

They have been fighting to take him to the United States for treatment.

There is lab evidence that the experimental treatment protocol for Charlie prepared by the Bambino Gesu' may work, according to a letter from Rome to London's Great Ormond Street Hospital which on Friday officially asked its doctors to be allowed to administer it.

Charlie made worldwide headlines earlier this month after President Donald Trump and Pope Francis commented on his case.

Charlie's parents, Chris Gard and Connie Yates, want to send their son to the USA for treatment of a rare genetic disorder that causes muscle deterioration and brain damage.


In addition to evaluating Charlie, Hirano will meet with doctors and others, on Monday and Tuesday, who have been caring for him.

The judge ruled that Charlie's mother Connie, from Bedfont, west London, can be present for the examination.

Doctors at Great Ormond Street argue life support should be withdrawn, saying that Charlie's condition - a form of mitochondrial disease which causes progressive muscle weakness and brain damage - would affect his quality of life.

Dr Hirano's research focuses on mitochondrial diseases and genetic myopathies and he has treated others with conditions similar to Charlie's. The hospital says Charlie should be allowed to die with dignity.

The case returned to the High Court following reports of new data from healthcare specialists who suggested that Charlie's condition could improve with the treatment.

Other reports by Ligue1talk

Discuss This Article

FOLLOW OUR NEWSPAPER